Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets boosted by earnings, Eurozone PMIs

Wed, 24th Jul 2013 11:23

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China.easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher after results or trading updates this morning. Meanwhile, figures from blue chips Daimler, Volvo and Alstom also impressed over in Europe.In economic data, the Eurozone purchasing managers' indices (PMIs) for both the services and manufacturing sectors beat expectations in July, pushing the composite PMI from 48.7 to 50.4, well ahead of the 49.1 consensus forecast. This was the best reading of private-sector activity in 18 months."Sure, unemployment remains frighteningly high, political instability keeps the market on its toes and deep austerity will be biting hard for some time, but services and manufacturing facets of the Eurozone economy are turning a page," said Market Strategist Ishaq Siddiqi from ETX Capital.Markets were also digesting comments from Goldman Sachs analysts who said they see a near 50% probability that the Monetary Policy Committee will modify its stance at the August meeting. The most likely change would be a cut in the Bank rate or remuneration rate on bank reserves, but additional quantitative easing looks less likely. Chinese data disappointsHSBC's flash China manufacturing PMI fell from 48.2 to 47.7 in July, missing expectations of no change. "Under normal circumstances, this would weigh heavily on investor sentiment and therefore risk assets, such as the European indices, however that is not the case this morning," said Market Analyst Craig Erlam from Alpari.Downside risks to growth were tempered yesterday by the country's Premier Li Keqiang who assured that the pace of expansion would not fall below the "bottom line" of 7.0% this year, indicating that any slowdown would be met with more stimulus."This should limit the short-term negativity surrounding poor Chinese data because it seems for now that growth is guaranteed to remain at these higher levels," Erlam said.FTSE 100: Updates from heavyweights impresseasyJet surged this morning after the budget airline achieved a 10.5% rise in third-quarter revenue to £1.14bn, bolstered by an increase in capacity and growth in revenue per seat. Chip designer ARM Holdings was also on the rise after delivering better-than-expected second-quarter sales and profits. The company also said that dollar revenues would be "at least in line" with market expectations.Food ingredients firm Tate & Lyle gained after saying that adjusted profits were in line with expectations in spite of tough weather conditions in the States in the first quarter.Foodservice and support services company Compass rose after saying expectations for the full year remain "positive and unchanged" following a strong third quarter.Kingfisher, the DIY retail group behind B&Q and Screwfix, said it is on track to hit expectations for the first half after a pick-up in activity in the second quarter, causing shares to rise.Pharmaceuticals giant GlaxoSmithKline was trading higher this morning ahead of its results out this afternoon.Exchange operator London Stock Exchange was subdued after going ex-dividend. Engineering and project management group AMEC was trading lower after HSBC downgraded the stock to 'neutral' and cut its target price from 1,200p to 1,130p.FTSE 100 - RiserseasyJet (EZJ) 1,439.00p +7.71%ARM Holdings (ARM) 940.50p +4.73%Glencore Xstrata (GLEN) 292.40p +3.43%Weir Group (WEIR) 2,173.00p +2.89%Tate & Lyle (TATE) 847.00p +2.85%International Consolidated Airlines Group SA (CDI) (IAG) 293.90p +2.80%Travis Perkins (TPK) 1,720.00p +2.69%Antofagasta (ANTO) 875.50p +2.16%Melrose Industries (MRO) 273.60p +1.90%TUI Travel (TT.) 371.00p +1.87%FTSE 100 - FallersMeggitt (MGGT) 538.00p -1.65%Croda International (CRDA) 2,421.00p -1.14%British Land Co (BLND) 610.00p -1.13%BG Group (BG.) 1,198.00p -1.03%Sage Group (SGE) 356.00p -0.84%Hammerson (HMSO) 533.50p -0.56%Amec (AMEC) 1,066.00p -0.56%Hargreaves Lansdown (HL.) 1,006.00p -0.40%Barclays (BARC) 320.45p -0.40%Fresnillo (FRES) 1,088.00p -0.28%FTSE 250 - RisersImagination Technologies Group (IMG) 269.20p +7.38%Wetherspoon (J.D.) (JDW) 708.00p +5.99%National Express Group (NEX) 259.00p +5.50%Hochschild Mining (HOC) 171.60p +4.63%Mitchells & Butlers (MAB) 433.30p +4.41%Bumi (BUMI) 225.00p +3.93%Premier Farnell (PFL) 228.40p +3.12%Dialight (DIA) 1,221.00p +3.04%Playtech (PTEC) 706.50p +2.39%St. Modwen Properties (SMP) 308.80p +2.18%FTSE 250 - FallersBeazley (BEZ) 215.90p -4.34%TalkTalk Telecom Group (TALK) 246.80p -2.06%Renishaw (RSW) 1,535.00p -2.04%Kier Group (KIE) 1,395.00p -1.97%Man Group (EMG) 86.15p -1.94%Chemring Group (CHG) 301.00p -1.67%Carpetright (CPR) 666.00p -1.62%Great Portland Estates (GPOR) 577.50p -1.45%Anite (AIE) 130.00p -1.44%Barr (A.G.) (BAG) 562.00p -1.23%BC
More News
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.